US2010136588A1PendingUtilityA1

Methods and Devices for Diagnosis of Appendicitis

56
Assignee: ASPENBIO PHARMA INCPriority: Jul 23, 2004Filed: Dec 15, 2009Published: Jun 3, 2010
Est. expiryJul 23, 2024(expired)· nominal 20-yr term from priority
G01N 33/6893G01N 2800/06Y10T436/10C12Q 2600/112C12Q 1/6883C12Q 2600/158
56
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A method is provided for determining the severity of appendicitis in a patient that includes testing a blood, serum or plasma sample from the patient for the quantity of MRP8/14 in the sample and comparing it with the quantity of MRP8/14 present in standard samples correlated with an appendicitis severity scoring system. A histologically-based appendicitis severity scoring system is also provided. Immunoassays and kits for performing the appendicitis assays of this invention are also provided, as are standard samples and data correlating MRP8/14 quantities present in patient samples to histologically-based appendicitis severity grades. The methods and immunoassay devices and kits of this invention are useful for managing the treatment of patients presenting with appendicitis symptoms.

Claims

exact text as granted — not AI-modified
1 . A method for medical management of patients suspected of appendicitis comprising:
 performing an immunoassay on a sample from said patient comprising comparing the degree of binding of MRP8/14 in said sample to an antibody to MRP8/14 to the degree of binding to said antibody of MRP8/14 in a standard sample containing an amount of MRP8/14 correlated to a predetermined appendicitis severity grading category; and   planning the patient's treatment in accordance with the results of said immunoassay.   
     
     
         2 . The method of  claim 1  further comprising, prior to performing said immunoassay, contacting a sample from said patient with a first antibody to MRP8/14 in an immunoassay device capable of determining the degree of binding of MRP8/14 in said sample to an anti-MRP8/14 antibody, wherein a visually-detectable signal is produced in said immunoassay device in response to a degree of binding indicative of appendicitis. 
     
     
         3 . The method of  claim 1  wherein said grading category is selected from the group consisting of:
 Grade 1 No identifiable inflammation in appendix tissue;   Grade 2 Inflammation extending through the mucosa and into the submucosa of the appendix   Grade 3 Inflammation extends past the submucosa into the muscular levels of the appendix   Grade 4 All layers of the appendix, including the serosa, inflamed, and perforation identified.   
     
     
         4 . The method of  claim 1  wherein the immunoassay is an ELISA. 
     
     
         5 . The method of  claim 4  wherein the sample is diluted at least about 100-fold before testing in said ELISA. 
     
     
         6 . The method of  claim 4  wherein said ELISA also comprises means for testing standard and control samples. 
     
     
         7 . The method of  claim 4  wherein said ELISA is completed within sixty minutes or less. 
     
     
         8 . The method of  claim 1  wherein, if said signal is not indicative of appendicitis, the patient is examined for other conditions having symptoms consistent with those of the patient. 
     
     
         9 . The method of  claim 1  wherein the patient's treatment plan is based on the results of said immunoassay. 
     
     
         10 . The method of  claim 9  wherein said treatment plan includes decisions regarding at least one parameter selected from the group consisting of:
 anticipated length of hospital stay; antibiotics dosage; type of antibiotics;   timing of administration of antibiotics; and timing of surgery.   
     
     
         11 . An immunoassay kit for determining the severity grade of appendicitis comprising an anti-MRP8/14 antibody and a means for detecting an immunoreaction product comprising MRP8/14 and the antibody. 
     
     
         12 . The immunoassay kit of  claim 11  also comprising a specific binding agent capable of binding to said anti-MRP8/14 antibody or to MRP8/14. 
     
     
         13 . The immunoassay kit of  claim 11  also comprising at least one enzyme-linked immunosorbent assay surface. 
     
     
         14 . The immunoassay kit of  claim 11  further comprising standard data showing a correlation of the quantity of MRP8/14 with appendicitis severity. 
     
     
         15 . The kit of  claim 11  further comprising at least one MRP8/14 standard. 
     
     
         16 . A standard sample comprising a quantity of MRP8/14 corresponding to a quantity of MRP8/14 known to be present in samples from patients having a known appendicitis grade. 
     
     
         17 . A set of standard samples of  claim 16  each comprising a quantity of MRP8/14 known to be present in samples from patients having a known appendicitis grade, wherein each standard sample in the set comprises a different quantity of MRP8/14. 
     
     
         18 . The set of standard samples of  claim 17  wherein each standard sample comprises a plurality of pooled samples from patients having the same known appendicitis grade. 
     
     
         19 . The set of standard samples of  claim 17  wherein said standard samples are synthetic samples comprising quantities of MRP8/14 known to correlate with a set of appendicitis grades. 
     
     
         20 . The set of standard samples of  claim 17  comprising at least two samples, each having a quantity of MRP8/14 correlated with a different appendicitis grade. 
     
     
         21 . The set of standard samples of  claim 17  comprising at least four samples, each having a quantity of MRP8/14 correlated with a different appendicitis grade. 
     
     
         22 . An electronic storage medium comprising a data set comprising data representative of MRP8/14 quantities correlated with appendicitis grades for which said quantities are diagnostic. 
     
     
         23 . A method of scoring the severity of appendicitis corresponding to histological condition of tissue of a patient suspected of suffering from appendicitis, said method comprising:
 examining tissue of the appendix and tissue adjacent thereto and assigning grade scores to describe the severity of appendicitis in said patient corresponding to the following condition of the tissue:   Grade 1 No identifiable inflammation in appendix tissue;   Grade 2 Inflammation extending through the mucosa and into the submucosa of the appendix;   Grade 3 Inflammation extends past the submucosa into the muscular levels of the appendix;   Grade 4 All layers of the appendix, including the serosa, inflamed, and perforation identified.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.